FFRangio System vs uMI Panvivo
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, the FFRangio System, is designed for AI-driven functional assessment of coronary artery disease to optimize PCI decisions, eliminating the need for invasive pressure wires. In contrast, Tool B, uMI Panvivo, is an AI-powered PET/CT system focused on high-resolution diagnostic imaging across oncology, cardiology, and neurology. While both leverage AI in cardiology, they serve distinct purposes: Tool A for interventional guidance and Tool B as a multi-specialty diagnostic modality.
Choose FFRangio System if…
Choose the FFRangio System if your primary need is to quickly and non-invasively assess the functional severity of coronary artery disease and optimize PCI decisions directly within the cath lab. This system is ideal for interventional cardiologists seeking real-time, wire-free FFR guidance to confirm lesion significance and evaluate treatment strategies without the need for pressure wires or vasodilating drugs.
View FFRangio System →Choose uMI Panvivo if…
Choose uMI Panvivo if your facility requires a versatile, high-resolution AI-powered PET/CT system for comprehensive diagnostic imaging across multiple specialties, including oncology, cardiology, and neurology. This system is best suited for institutions prioritizing advanced imaging precision, efficient AI-driven workflows, and a scalable platform that can be integrated into various departmental or enterprise solutions.
View uMI Panvivo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FFRangio System | uMI Panvivo |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| Deployment | SaaS, on-prem, hybrid | On-premise |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FFRangio System | uMI Panvivo |
|---|---|---|
| Name | FFRangio System | uMI Panvivo |
| Company | CathWorks | Shanghai United Imaging Healthcare Co., Ltd. |
| Description | The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease. | uMI Panvivo is an AI-powered PET/CT system by Shanghai United Imaging Healthcare Co., Ltd., offering advanced diagnostic precision with high-resolution imaging and intelligent workflows for oncology, cardiology, and neurology. |
| Categories | Cardiology AI, Surgical AI | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specialties | Cardiology | Nuclear Medicine, Oncology, Radiology |
| Key Features | Real-time FFRangio values at every point on the coronary tree; Simulated pullback curve differentiates functional patterns of CAD; Lesion Impact feature to assess residual ischemia; Integrated sizing tool for non-invasive lesion measurements; Intuitive user interface; Artificial intelligence aids in quick angiogram analysis; Seamless integration with cath lab boom and PACS; Eliminates the need for invasive pressure wires, drugs, or a guide catheter | AI-powered workflow (uVision, EasyRange, OncoFocus, NeuroFocus, uExcel DPR); High NEMA spatial resolution (2.9mm); Exceptional TOF timing resolution (219 ps); Air-cooled compact design (fits in ~22mu00b2 rooms); Large tunnel clearance (up to 59cm); Ambient lighting with breathing guide; Collision-avoidance design; Scalable platform |
Videos
Demos, reviews, and walkthroughs featuring FFRangio System and uMI Panvivo.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
The FFRangio System is specifically designed for interventional cardiology, providing wire-free and drug-free 3D FFR guidance to optimize PCI decisions for patients with coronary artery disease. The uMI Panvivo is an AI-powered PET/CT system offering advanced diagnostic imaging for a broader range of specialties including oncology, cardiology, and neurology.
The FFRangio System uses artificial intelligence to analyze routine angiograms and generate real-time 3D FFR values, simulated pullback curves, and lesion impact assessments. The uMI Panvivo is a high-resolution PET/CT imaging system that leverages AI-powered workflows for image acquisition, reconstruction, and analysis, featuring exceptional spatial and TOF timing resolution.
The FFRangio System eliminates the need for invasive pressure wires and hyperemic drugs, which can reduce risk, radiation exposure, and improve patient comfort during PCI procedures. The uMI Panvivo enhances diagnostic precision with high-resolution imaging and intelligent workflows, while its patient-centric design, including large tunnel clearance and ambient lighting, aims to reduce patient anxiety and claustrophobia.
Both systems have received FDA clearance. The FFRangio System is ISO 27001 certified for information security, while the uMI Panvivo explicitly states it is HIPAA compliant and includes a Business Associate Agreement (BAA).
The FFRangio System provides real-time FFRangio values at every point on the coronary tree, simulated pullback curves to differentiate CAD patterns, and a Lesion Impact feature to assess residual ischemia for PCI optimization. The uMI Panvivo delivers high-resolution anatomical and functional images, along with AI-powered tools like OncoFocus and NeuroFocus, to aid in the detection, evaluation, diagnosis, and monitoring of various conditions across oncology, cardiology, and neurology.